192 related articles for article (PubMed ID: 1503919)
1. Neuroblastoma in the very young child: biological considerations.
Kemshead JT; Patel K; Phimister B
Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
3. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
4. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
7. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
[TBL] [Abstract][Full Text] [Related]
8. [Management strategy in neuroblastoma].
Balwierz W
Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
[TBL] [Abstract][Full Text] [Related]
9. [Limitations in the histopathologic diagnosis and prognosis of neuroblastoma].
Mihăilă D; Aprodu G; Ionescu C; Miron I; Maxim E; Plămădeală P
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):834-40. PubMed ID: 14756030
[TBL] [Abstract][Full Text] [Related]
10. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma imaging.
Ley S; Ley-Zaporozhan J; Günther P; Deubzer HE; Witt O; Schenk JP
Rofo; 2011 Mar; 183(3):217-25. PubMed ID: 21170823
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biology markers of neuroblastoma as the basis for a therapy concept].
Girgert R; Treuner J; Schweizer P
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1053-5. PubMed ID: 9101780
[TBL] [Abstract][Full Text] [Related]
13. [Cervical neuroblastoma in an infant].
Arvai K; Tóth J; Németh T; Kiss C; Molnár P; Oláh E
Magy Onkol; 2004; 48(1):89-95. PubMed ID: 15105902
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
Grosfeld JL; Rescorla FJ; West KW; Goldman J
Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma: new approaches to diagnosis.
Kemshead JT; Lashford LS; Garson J; Clayton J
Cancer Surv; 1987; 6(2):227-246. PubMed ID: 3322546
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology and genetics of neuroblastoma.
Tay JS
J Singapore Paediatr Soc; 1991; 33(3-4):80-7. PubMed ID: 1812339
[No Abstract] [Full Text] [Related]
17. Accumulation of segmental alterations determines progression in neuroblastoma.
Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma: the challenge and frustration.
Finklestein JZ
Hematol Oncol Clin North Am; 1987 Dec; 1(4):675-94. PubMed ID: 3323179
[TBL] [Abstract][Full Text] [Related]
20. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]